R R

How Many People Undergo Corneal Cross-Linking for Keratoconus?

Corneal cross-linking (CXL) is a relatively new procedure for stabilizing keratoconus (a disorder causing corneal thinning and bulging). Due to the growing awareness and improved technology, the number of procedures performed globally is rising steadily, often exceeding 100,000 cases annually. The procedure's adoption is rapid in developed nations where keratoconus screening is routine. This widespread adoption reflects the procedure's high success rate in halting disease progression.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

How Many People Undergo Corneal Cross-Linking for Keratoconus?

Corneal cross-linking (CXL) is a relatively new procedure for stabilizing keratoconus (a disorder causing corneal thinning and bulging). Due to the growing awareness and improved technology, the number of procedures performed globally is rising steadily, often exceeding 100,000 cases annually. The procedure's adoption is rapid in developed nations where keratoconus screening is routine. This widespread adoption reflects the procedure's high success rate in halting disease progression.

read more about keratoconus corneal cross-linking statistics ...

Copy this HTML:

Copy HTML Copied!

What is the Goal of the Procedure and How is it Performed?

The goal is to halt the progression of corneal thinning and bulging. The procedure involves applying riboflavin drops (Vitamin B2) to the cornea, followed by exposure to controlled ultraviolet (UV-A) light. This combination causes new collagen bonds to form, which stiffens the corneal tissue. The strengthening of the cornea prevents further distortion and stabilizes the patient's vision.

What are the Key Age Patterns for Treatment?

Treatment is strongly focused on younger patients, typically adolescents and young adults. The treatment is most effective when performed early, as soon as keratoconus progression is confirmed. Stabilizing the cornea during the years of fastest growth is necessary to prevent severe vision loss later in life. Treatment in older adults is less common because the cornea naturally stiffens with age.

What are the Main Outcomes of the Cross-Linking Procedure?

The main outcome is stabilization. Studies show that CXL is highly successful, halting the progression of keratoconus in over 90 percent of treated eyes. In some cases, the procedure can lead to minor flattening of the cornea, which improves vision slightly. The procedure significantly reduces the lifetime risk of needing a corneal transplant.

Why is Early Screening Necessary for Keratoconus?

Early screening is necessary because the window for effective cross-linking closes when the cornea becomes too thin or too steep. Regular comprehensive eye exams are needed for early detection of subtle corneal shape changes, especially in teenagers and young adults.

How Does This Procedure Affect Contact Lens Wear?

Corneal cross-linking is often followed by continued use of specialized contact lenses (like rigid gas permeable or scleral lenses). The procedure stabilizes the corneal shape, allowing the patient to be fitted more precisely and comfortably with these specialized contact lenses.

FAQs on Corneal Cross-Linking

Is the procedure painful?

No, the eye is numbed during the procedure. Patients may feel discomfort for a few days afterward.

Is CXL used for all eye problems?

No, CXL is used specifically to treat progressive keratoconus and other forms of corneal weakening.

Does it cure keratoconus?

No, it does not cure the disorder, but it successfully halts the progression of the vision loss.

When to See Your Doctor

If your glasses prescription changes rapidly, or if you notice distorted vision (straight lines appear wavy), see an eye doctor immediately. Prompt referral to a corneal specialist is necessary to perform cross-linking before the cornea becomes too thin.

References

  • American Academy of Ophthalmology. Corneal Cross-linking (CXL) for Keratoconus: Treatment Outcomes and Safety (aao.org/eye-health/treatments/corneal-cross-linking). 2025.
  • Journal of Cataract & Refractive Surgery. Ten-year clinical results of corneal collagen cross-linking for progressive keratoconus (journals.lww.com/jcrs/fulltext/2025/11000/ten_year_results_cxl.aspx). 2025.
  • Cornea. Global Volume and Trends in Corneal Cross-linking: A 2024 Survey of Ophthalmic Surgeons (journals.lww.com/corneajrnl/Fulltext/2024/09000/Global_Trends_in_CXL.12.aspx). 2024.
  • British Journal of Ophthalmology. Pediatric Keratoconus: The Role of Accelerated CXL in Preventing Visual Impairment (bjo.bmj.com). 2025.
  • Cureus Journal of Medical Science. Comparison of Epi-on and Epi-off Corneal Cross-linking: A Meta-analysis of Stabilization Rates (cureus.com/articles/214562-epi-on-vs-epi-off-cxl). 2025.